Literature DB >> 26873410

Combined Treatment with Systemic and Local Delivery of Substance P Coupled with Self-Assembled Peptides for a Hind Limb Ischemia Model.

Ji Eun Kim1,2, Ki Moon Jung1, Soo Hyun Kim1,2,3, Youngmee Jung1,3.   

Abstract

When treating critical limb ischemia caused by various chronic diseases such as diabetes and hypertension, it is essential to effectively induce angiogenesis to supply blood flow to the ischemic region. Recently, several studies have investigated the effects of cell transplantation with mesenchymal stem cells (MSCs) as a therapeutic modality for treating these ischemic diseases. However, some limitations have to be overcome first before cell transplantation can be considered as a promising treatment for ischemic diseases, such as limited sources of cells and the low survival rates of transplanted cells. In this study, self-assembled peptide (SAP) hydrogels coupled with substance P (SP) were used to induce the recruitment of MSCs in an injury site in mouse ischemic hind limb models without exogenous injection of cells. In addition, a combined delivery strategy consisting of local and systemic delivery of SP was used to examine the synergetic effects of systemic and local deliveries. Limb ischemia in athymic mice was induced through the femoral artery by ligating and resecting its branches, and SAP coupled with SP (bioactive SAPs) was injected into the ischemic region. The therapeutic effects on the ischemic region were observed in terms of cell migration, fibrosis, apoptosis, and angiogenesis in each experimental group. The combined therapeutic delivery system resulted in the recruitment of more cells for effective regeneration, promotion of neovascularization, and formation of mature vessels for tissue perfusion and inhibition of fibrosis and cell apoptosis than a single treatment. In conclusion, it was confirmed that the combined therapy of local and system delivery of the SP-conjugated peptide hydrogels and SP could effectively enhance the mobilization of host cells related to angiogenesis to injured tissue, and consequently, they could be useful in treating ischemic diseases without cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26873410     DOI: 10.1089/ten.TEA.2015.0412

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  6 in total

Review 1.  Biomaterials for recruiting and activating endogenous stem cells in situ tissue regeneration.

Authors:  Ingrid Safina; Mildred C Embree
Journal:  Acta Biomater       Date:  2022-03-12       Impact factor: 10.633

2.  Stem-Cell Therapy for Esophageal Anastomotic Leakage by Autografting Stromal Cells in Fibrin Scaffold.

Authors:  Xiang Xue; Yan Yan; Ye Ma; Yang Yuan; Chunguang Li; Xilong Lang; Zhiyun Xu; Hezhong Chen; Hao Zhang
Journal:  Stem Cells Transl Med       Date:  2019-02-27       Impact factor: 6.940

Review 3.  Therapeutic Biomaterial Approaches to Alleviate Chronic Limb Threatening Ischemia.

Authors:  Grazia Marsico; Sergio Martin-Saldaña; Abhay Pandit
Journal:  Adv Sci (Weinh)       Date:  2021-02-08       Impact factor: 16.806

Review 4.  Administration of signalling molecules dictates stem cell homing for in situ regeneration.

Authors:  Xuan Li; Xiao-Tao He; Yuan Yin; Rui-Xin Wu; Bei-Min Tian; Fa-Ming Chen
Journal:  J Cell Mol Med       Date:  2017-08-02       Impact factor: 5.310

5.  In situ cardiac regeneration by using neuropeptide substance P and IGF-1C peptide eluting heart patches.

Authors:  Muhammad Shafiq; Yue Zhang; Dashuai Zhu; Zongxian Zhao; Dong-Hwee Kim; Soo Hyun Kim; Deling Kong
Journal:  Regen Biomater       Date:  2018-10-12

Review 6.  The Regenerative Potential of Substance P.

Authors:  Patrycja Redkiewicz
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.